Benign neoplasms refer to new growths that do not spread to other areas of the body or permeate tissue. In this case, the growth involves the genitourinary (GU) system which includes the kidneys, ureters, bladder, and urethra for men and women, and the prostate gland, penis, testis, and scrotum, for men, only. For benign neoplasms related to women's genitourinary system, see Diagnostic Code: 7628 Benign neoplasms of the gynecological system or breast.

Benign growths related to this system may occur at any age in both sexes, and develop in the form of a cyst, mass, or tumor. Cysts may form as a result of abnormal development, obstruction of ducts, or infection. Tumors or masses usually form from unknown causes termed noninflammatory, and develop without regard to normal growth patterns. Most solid tumors are found in the testes in males less than thirty years of age. For organs specific to women, see Diagnostic Code: 7628 Benign neoplasms of the gynecological system or breast.

Local tissue invasion from a cyst, mass, or tumor can result in pressure on normal tissues, which can lead to inflammation. In addition, obstructive symptoms may occur (disruption in urinary or semen flow), and hematuria (blood in the urine) may appear. Bleeding into the tumor may result in local pain and tenderness. Some men have pain or discomfort resulting from a mass, whereas the enlargement may be painless.

A physical examination that includes a bimanual examination assists in the diagnosis. Other diagnostic measures include: cystography; urinary cytology studies; cystoscopy; computed tomography (CT) scan; magnetic resonance imaging (MRI); abdominal ultrasound; and intravenous (IV) urography. For tests related to organs specific to women, see Diagnostic Code: 7628 Benign neoplasms of the gynecological system or breast.

In most parts of the body, a benign tumor causes few or no problems; however, some benign new growths, e.g., those that cause obstructive symptoms, may need surgical resection or ablation via laser or other means. For treatments related to organs specific to women, see Diagnostic Code: 7628 Benign neoplasms of the gynecological system or breast.

Benign disease is nonmalignant. However, some growths will require surgery, and patients will undergo a postoperative recovery phase with possible incision, sutures, and wound healing. For residuals related to organs specific to women, see Diagnostic Code: 7628 Benign neoplasms of the gynecological system or breast.

• May be entitled to special monthly compensation where the Veteran has a single service-connected disability rated as 100% with additional service-connected disability or disabilities independently ratable at 60% or more, which are separate and distinct from the 100% service-connected disability and involves different anatomical segments or bodily systems. See  38 CFR 3.350(i)(1) – Special Monthly Compensation (SMC).

• The new criteria for the Genitourinary Disease and Conditions body system became effective November 14, 2021.  Review both current and historic criteria prior to any reduction for disabilities established before that date.  38 CFR 3.951(a)

• When evaluating any claim involving loss or loss of use of one or more creative organs, refer to 38 CFR 3.350 of this chapter to determine whether the Veteran may be entitled to special monthly compensation. Footnotes in the schedule indicate conditions which potentially establish entitlement to special monthly compensation; however, there are other conditions in this section which under certain circumstances also establish entitlement to special monthly compensation.

• GFR, estimated GFR (eGFR), and creatinine-based approximations of GFR will be accepted for evaluation purposes when determined to be appropriate and calculated by a medical professional.